Galera Therapeutics's market cap is currently $1.78M. The company's EPS TTM is $-0.016; its P/E ratio is -0.11; Galera Therapeutics is scheduled to report earnings on May 19, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
